Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Unipharma Co., Ltd. (6621) Financial Statements

Unipharma Co., Ltd. Financial Overview

Unipharma Co., Ltd.'s market cap is currently NT$431.34M. The company's EPS TTM is NT$-1.13; its P/E ratio is -10.80; Unipharma Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 88.44MNT$ 93.45MNT$ 103.22MNT$ 128.11MNT$ 105.39M
Gross ProfitNT$ 41.15MNT$ 48.71MNT$ 51.02MNT$ 74.62MNT$ 59.33M
Operating IncomeNT$ -44.13MNT$ -30.82MNT$ -27.30MNT$ -20.88MNT$ -40.22M
EBITDANT$ -37.13MNT$ -17.71MNT$ -16.25MNT$ -1.45MNT$ -63.52M
Net IncomeNT$ -40.54MNT$ -24.82MNT$ -21.81MNT$ -6.45MNT$ -74.41M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 135.35MNT$ 158.83MNT$ 174.18MNT$ 169.26MNT$ 175.46M
Total AssetsNT$ 274.99MNT$ 328.98MNT$ 350.07MNT$ 332.57MNT$ 348.18M
Total DebtNT$ 10.98MNT$ 14.78MNT$ 277.00KNT$ 3.53MNT$ 6.99M
Net DebtNT$ -18.02MNT$ -43.89MNT$ -68.37MNT$ -60.23MNT$ -68.96M
Total LiabilitiesNT$ 45.20MNT$ 44.22MNT$ 37.40MNT$ 29.33MNT$ 50.61M
Stockholders' EquityNT$ 229.79MNT$ 284.75MNT$ 312.67MNT$ 303.24MNT$ 297.57M
Cash Flow
Free Cash FlowNT$ -37.99MNT$ -17.16MNT$ 3.92MNT$ -32.09MNT$ -16.14M
Operating Cash FlowNT$ -36.68MNT$ -14.32MNT$ 12.03MNT$ -31.65MNT$ -12.93M
Investing Cash FlowNT$ 10.67MNT$ 8.18MNT$ -3.89MNT$ -1.12MNT$ 19.80M
Financing Cash FlowNT$ -3.67MNT$ -3.83MNT$ -3.26MNT$ 20.57MNT$ -5.49M

Currency in TWD

Unipharma Co., Ltd. Earnings and Revenue History

-100M0100M200M-80 %-40 %0 %40 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Unipharma Co., Ltd. Liabilities to Assets

0200M400M600M5 %10 %15 %20 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Unipharma Co., Ltd. Cash Flow

-75M-50M-25M025M50M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Unipharma Co., Ltd. Forecast EPS vs Actual EPS

Earnings >